NASHVILLE, Tenn. , Nov. 4, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...
NASHVILLE, Tenn. , Oct. 28, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that it will release its third quarter 2025...
Cumberland to expand its gastroenterology offerings with the market-leading Helicobacter pylori therapy
Premier Membership includes 4,350 U.S. Hospitals
Injectable Ibuprofen Approved for Treating Pain & Fever
Vibativ ® treats patients with pneumonia and serious skin infections
NASHVILLE, Tenn. , Aug. 5, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved...
Vizient serves more than 65% of the nation's acute care providers, including 97% of academic medical centers